Merger Update: Watson, Actavis
The settlement of an antitrust action has put the acquisition of Actavis Inc. by Watson Pharmaceuticals back on track with a $5.9 billion price tag. According to the complaint filed with...To view the full article, register now.
Already a subscriber? Click here to view full article